Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$13.78 - $18.8 $719,784 - $981,999
52,234 New
52,234 $982 Million
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $6,503 - $9,317
-392 Reduced 16.19%
2,029 $35.2 Million
Q2 2023

Nov 13, 2023

SELL
$19.27 - $24.63 $8.37 Million - $10.7 Million
-434,414 Reduced 99.45%
2,421 $50.4 Million
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $8.42 Million - $10.8 Million
436,835 New
436,835 $9.09 Billion

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Uni Super Management Pty LTD Portfolio

Follow Uni Super Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uni Super Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uni Super Management Pty LTD with notifications on news.